Rate My Professor Allison Norlander

Dr. Norlander has published extensively on T cell immunology in cardiovascular and respiratory diseases. Key works include "The Immunology of Hypertension" (Journal of Experimental Medicine, 2018), a review garnering over 500 citations; "Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension" (Hypertension, 2016); "A Salt-Sensing Kinase in T Lymphocytes, SGK1, Drives Hypertension and Hypertensive End-Organ Damage" (JCI Insight, 2017); and more recent papers such as "Prostaglandin I2 Signaling Licenses Treg Suppressive Function and Prevents Pathogenic Reprogramming" (Journal of Clinical Investigation, 2021) and "Prostaglandin I2 Therapy Promotes Treg Generation in Patients with Pulmonary Arterial Hypertension" (American Journal of Respiratory and Critical Care Medicine, 2023). Her research has been supported by the American Heart Association predoctoral fellowship during graduate training and the National Institutes of Health K99/R00 Pathway to Independence Award (HL159594, PI, 2021-2025), funding investigations into PGI2 effects on T cells and dendritic cells in hypertension. These contributions have advanced understanding of immune-driven inflammation in hypertension and allergy.